IL-12, Human, Standard TMB ELISA Development Kit

Katalog-Nummer NB-50-1462-1000

Size : 1000Tests

Marke : Neo Biotech

Weitere Informationen anfordern

Contact local distributor :


Telefonnummer : +1 850 650 7790

Product Specifications

Analytical sensitivity

Lot-specific

Assay range

Lot-specific

Hands-on time

1 hr 45 min

Time-to-result

24 hr 30 min

Homogenous (no wash)

No

Instrument

Colorimetric Microplate Reader

Product size

10 x 96 Tests

Contents

This Human IL-12 p70 ELISA Kit includes Capture Antibody, Detection Antibody, Protein Standard, and HRP-conjugate. The HRP-conjugate is packaged separately.

Storage

Refer to product documentation for component specific storage temperature.

Protein name

IL-12 p70

Protein family

Growth Factors & Receptors

Species (tested)

Human

Assay kit format

ELISA Development Kit

Detector antibody conjugate

Biotin

Label or dye

HRP

About This Kit

900-T96K consists of: 900-T96 (capture antibody, detection antibody, and protein standard), and HRP-17UL (streptavidin HRP-conjugate).

Human IL-12 p70 TMB ELISA Development Kit contains the key components required for the quantitative measurement of natural and/or recombinanthuman IL-12 p70 in a sandwich ELISA format. Human IL-12 p70 TMB ELISA Development Kit contains enough material to assay the target cytokine in at least 1,000 ELISA plate wells.

The TMB ELISA Buffer Kit (Product # 900-T00), sold separately, is recommended to be used in conjunction with this TMB ELISA Development Kit for optimal performance. This buffer kit contains all the necessary components to assay ten 96-well ELISA plates (included) and contains detailed handling instructions.

Target information

IL-12 p70, also known as interleukin-12, is a cytokine that plays a critical role in the immune system's response to infections and cancer. It is produced by immune cells, including dendritic cells, macrophages, and B cells, in response to certain pathogens and tumor cells. IL-12 p70 stimulates the production of interferon-gamma and other cytokines, which promote the activation and proliferation of T cells and natural killer cells. IL-12 p70 has been studied as a potential therapeutic target for various diseases and conditions, including infectious diseases, autoimmune disorders, and cancer. It has been shown to enhance immune responses against certain infections and tumors, and to modulate inflammatory responses in autoimmune diseases.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.